Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Medical Genetics and Applied Genomics, |
RCV001268709 | SCV001447837 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001268709 | SCV002168958 | pathogenic | not provided | 2022-10-04 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 987368). This premature translational stop signal has been observed in individual(s) with retinitis pigmentosa (PMID: 28559085). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys73*) in the PRPF31 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PRPF31 are known to be pathogenic (PMID: 18317597, 23950152). |
Ce |
RCV001268709 | SCV003918184 | pathogenic | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | PRPF31: PVS1, PM2, PS4:Moderate |
Institute of Human Genetics, |
RCV004814056 | SCV005068466 | pathogenic | Retinal dystrophy | 2023-01-01 | criteria provided, single submitter | clinical testing |